|
⚲
|
| Keyboard |
| Vitangcol Alvin
✚
|
|
|---|---|
| CIK # | 0001647556 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001647556] | |
| 4 | [0001647556] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Vitangcol Alvin | |
| ProNAi Therapeutics Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
ProNAi Therapeutics Inc DNAI
Common Stock
|
2015-07-21 | Conversion | 287,631 | ||
|
ProNAi Therapeutics Inc DNAI
Common Stock
|
2015-07-21 | Conversion | 471,242 | ||
|
ProNAi Therapeutics Inc DNAI
Common Stock
|
2015-07-21 | Other | 39,889 | $5.22 | 208,221 |
|
ProNAi Therapeutics Inc DNAI
Series C Preferred Stock Warrant (right to buy) · derivative
|
2015-07-21 | Option exercise | 126,558 | $5.22 | 660,633 |
|
ProNAi Therapeutics Inc DNAI
Series C Preferred Stock · derivative
|
2015-07-21 | Option exercise | 126,558 | ||
|
ProNAi Therapeutics Inc DNAI
Series C Preferred Stock · derivative
|
2015-07-21 | Tax withheld | 38,824 | ||
|
ProNAi Therapeutics Inc DNAI
Series D Preferred Stock · derivative
|
2015-07-21 | Conversion | 287,631 | ||
|
ProNAi Therapeutics Inc DNAI
Series C Preferred Stock · derivative
|
2015-07-21 | Conversion | 471,242 |